Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bristol-Myers Squibb (NY: BMY ) 44.03 -0.08 (-0.18%) Official Closing Price Updated: 7:00 PM EDT, May 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Bristol-Myers Squibb < Previous 1 2 ... 5 6 7 8 9 10 11 12 13 ... 41 42 Next > Merck and Bristol Myers Squibb Will Face Off in This 1 Market -- but Who Will Win? November 11, 2023 There's a lot more at stake than bragging rights. Via The Motley Fool Decoding Bristol-Myers Squibb's Options Activity: What's the Big Picture? November 09, 2023 Via Benzinga 3 No-Brainer Stocks to Buy With $500 Right Now November 08, 2023 A reasonably modest amount of money can go a long way when it's invested in time-tested businesses with sustained catalysts. Via The Motley Fool 8 Health Care Stocks Whale Activity In Today's Session November 07, 2023 Via Benzinga Christopher Boerner To Take The Helm At Bristol Myers Squibb As Chair Of The Board, CEO October 31, 2023 Via Benzinga Looking At Bristol-Myers Squibb's Recent Unusual Options Activity October 30, 2023 Via Benzinga Is NYSE:BMY suited for dividend investing? October 30, 2023 Is BRISTOL-MYERS SQUIBB CO (NYSE:BMY) suited for dividend investing? Via Chartmill Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week October 30, 2023 S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week. Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities Why LianBio Stock Is Skyrocketing Today October 24, 2023 Investors are loving LianBio's new deal with Bristol Myers Squibb. Via The Motley Fool Week In Review: Hansoh Sells Ex-China ADC Rights To GSK In $1.6 Billion Deal October 28, 2023 Hansoh Pharma sold ex-China rights for its B7-H4 ADC to GSK in a $1.57 billion deal. Meanwhile, OrbiMed has raised $4.3 billion in commitments for three healthcare funds, including $751 million for its... Via Talk Markets Pharma Giant Bristol-Myers Stock At 52-Week Low: Analyst Sees Uncertainty In Near-Term Outlook October 27, 2023 Bristol-Myers Squibb Co (NYSE: BMY) shares are trading lower on continuous weakness following the disappointing Q3 earnings and a downward revision to the Via Benzinga Bristol Myers Squibb Analysts Slash Their Forecasts Following Q3 Results October 27, 2023 Bristol Myers Squibb & Co (NYSE: BMY) reported better-than-expected earnings for its third quarter. Via Benzinga Stock Market Correction Intensifies; Google, Meta, Microsoft, Amazon Are Big Earnings Movers: Weekly Review October 27, 2023 Microsoft, Google, Amazon and Meta led big earnings. Via Investor's Business Daily What 12 Analyst Ratings Have To Say About Bristol-Myers Squibb October 20, 2023 Via Benzinga Bristol Myers Squibb (BMY) Q3 2023 Earnings Call Transcript October 26, 2023 BMY earnings call for the period ending September 30, 2023. Via The Motley Fool Topics Earnings Exposures Financial US Stocks Mixed; Bristol Myers Posts Upbeat Earnings October 26, 2023 U.S. stocks traded mixed this morning, following the release of several economic reports. Following the market opening Thursday, the Dow traded up 0.10% to 33,069.66 while the NASDAQ fell 0.24% to... Via Benzinga Topics Stocks Exposures US Equities Bristol Myers Squibb's Revlimid Sales Plunge 41%, but Opdivo and Eliquis Boost Q3, Stock Dips October 26, 2023 Bristol Myers Squibb & Co (NYSE: BMY) said that its Q3 revenues of $10.966 billion declined 2% Y/Y, or 3% when adjusted for foreign exchange, due to lower sales of Revlimid, partially offset by in-line... Via Benzinga Bristol Myers Skids 5% After Pushing Back A Key Sales Milestone By A Year October 26, 2023 The company expects its new drugs to reach $10 billion in sales by 2026. Via Investor's Business Daily Nasdaq Futures Plunge As Meta Warns Of Q4 Softness: GDP Data, Amazon Earnings On Investors' Radar Amid Market Mayhem October 26, 2023 Stock futures are plunging after the mega-cap tech names haven't turned in the strong results that the markets had factored in. Via Benzinga 2 Absurdly Cheap Healthcare Stocks to Buy and Hold for Decades October 26, 2023 You won't have to worry about paying a premium for either one of these stocks -- and they both pay a solid dividend. Via The Motley Fool Meta, Amazon And 3 Stocks To Watch Heading Into Thursday October 26, 2023 With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows: Via Benzinga Fear Continues To Grip Markets As S&P 500 Settles Below 4,200 October 26, 2023 The CNN Money Fear and Greed index showed growth easing in the overall fear level, remaining in the "Fear" zone on Wednesday. U.S. stocks closed lower on Wednesday, with the S&P 500 closing the session... Via Benzinga Topics Stocks Exposures US Equities META Up +4% On +23% Revenue Growth; IBM And NOW Also Beat October 25, 2023 Markets sagged throughout the course of today’s trading session after starting mixed, with the Dow basking in Microsoft’s stellar previous-afternoon’s earnings report. Via Talk Markets Topics Stocks Exposures US Equities This Artificial Intelligence (AI) Stock Is Powering the Biotech Revolution: Should You Invest? October 25, 2023 There's more to the AI boom than Microsoft and ChatGPT. Via The Motley Fool Topics Artificial Intelligence Exposures Artificial Intelligence Why Is LianBio (LIAN) Stock Up 130% Today? October 24, 2023 With LianBio inking a key exclusive licensing agreement with Bristol-Myers Squibb, LIAN stock is jumping up on the credibility implications. Via InvestorPlace Why LianBio Stock Is Ripping Higher Today October 24, 2023 LianBio (NASDAQ: LIAN) shares are trading higher Tuesday after the company announced an agreement with Bristol Myers Squibb (NYSE: BMY) to purchase LianBio's exclusive rights to develop and... Via Benzinga 'Never Buy A Drug Stock Just For The Yield': Jim Cramer On This Big Pharma Company October 24, 2023 On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended selling Petróleo Brasileiro S.A. - Petrobras (NYSE: PBR). Via Benzinga Which Is the Better Long-Term Hold for Investors: Pfizer or Roche? October 21, 2023 The venerable pharmaceutical companies' shares have slumped this year. Via The Motley Fool Amazon, Alphabet, Meta, Intel Q3 Earnings This Week: Will Mega-Caps Shatter Forecasts And Revive Market? October 23, 2023 Factset data indicates that out of the 17% of the S&P 500 companies that have reported so far, 73% have reported positive EPS surprises. Via Benzinga Topics Stocks Exposures US Equities Investor Risk Sentiment Wavers Amid War, Interest Rate Concerns; Tesla Earnings Disappoint: The Week In The Markets October 20, 2023 In the week ahead, earnings season moves into full swing with reports from companies like Microsoft, Alphabet, Meta Platforms and Amazon. Via Benzinga < Previous 1 2 ... 5 6 7 8 9 10 11 12 13 ... 41 42 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.